UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000021182
Receipt No. R000024425
Official scientific title of the study Multi-institutional study of immunologic response tu surgical stress in patients undergoing pulmonary lobectomy
Date of disclosure of the study information 2016/02/25
Last modified on 2018/08/29 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Multi-institutional study of immunologic response tu surgical stress in patients undergoing pulmonary lobectomy
Title of the study (Brief title) Immunologic response to surgical stress of lobectomy
Region
Japan

Condition
Condition Lung cancer
Classification by specialty
Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to investigate an immunologic response according to trauma size paitents undergoing pulmonary lobectomy.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Association between trauma size and short-term outcome including immunologic response and morbidity
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Need for lobectomy
That consent is obtained
Key exclusion criteria The person in charge ise determined to be inappropriate
Target sample size 100

Research contact person
Name of lead principal investigator Risa Oda
Organization Nagoya City University
Division name Department of Oncology,Immunology and Surgery
Address 1 kawasumi,mizuho-cho,mizuho-ku,Nagoya,Aichi,Japan
TEL 052-853-8231
Email pear_pear111@yahoo.co.jp

Public contact
Name of contact person Risa Oda
Organization Nagoya City University
Division name Department of Oncology,Immunology and Surgery
Address 1 kawasumi,mizuho-cho,mizuho-ku,Nagoya,Aichi,Japan
TEL 052-853-8231
Homepage URL
Email pear_pear111@yahoo.co.jp

Sponsor
Institute Nagoya City University
Institute
Department

Funding Source
Organization Nagoya City University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 25 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 01 Month 08 Day
Anticipated trial start date
2016 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information object:patiants who underwent lobectomy for clinical stage 1A lung cancer.
measurement item:IL-4,6,8,10,Hb,WBC,Plt,CRP etc.

Management information
Registered date
2016 Year 02 Month 24 Day
Last modified on
2018 Year 08 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024425